Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.
Fais M, Sanna G, Galioto M, Nguyen TTD, Trần MUT, Sini P, Carta F, Turrini F, Xiong Y, Dawson TM, Dawson VL, Crosio C, Iaccarino C. Fais M, et al. Among authors: sini p. Cells. 2021 Jan 20;10(2):203. doi: 10.3390/cells10020203. Cells. 2021. PMID: 33498474 Free PMC article.
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
Rassu M, Biosa A, Galioto M, Fais M, Sini P, Greggio E, Piccoli G, Crosio C, Iaccarino C. Rassu M, et al. Among authors: sini p. J Cell Mol Med. 2019 Dec;23(12):8505-8510. doi: 10.1111/jcmm.14674. Epub 2019 Sep 27. J Cell Mol Med. 2019. PMID: 31560168 Free PMC article.
On completely homogeneous c-spaces.
Sini P. Sini P. Heliyon. 2020 Dec 23;6(12):e05747. doi: 10.1016/j.heliyon.2020.e05747. eCollection 2020 Dec. Heliyon. 2020. PMID: 33409384 Free PMC article.
Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases.
Sini P, Gürtler U, Zahn SK, Baumann C, Rudolph D, Baumgartinger R, Strauss E, Haslinger C, Tontsch-Grunt U, Waizenegger IC, Solca F, Bader G, Zoephel A, Treu M, Reiser U, Garin-Chesa P, Boehmelt G, Kraut N, Quant J, Adolf GR. Sini P, et al. Mol Cancer Ther. 2016 Oct;15(10):2388-2398. doi: 10.1158/1535-7163.MCT-16-0066. Epub 2016 Aug 5. Mol Cancer Ther. 2016. PMID: 27496137
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.
Azzariti A, Bocci G, Porcelli L, Fioravanti A, Sini P, Simone GM, Quatrale AE, Chiarappa P, Mangia A, Sebastian S, Del Bufalo D, Del Tacca M, Paradiso A. Azzariti A, et al. Among authors: sini p. Br J Cancer. 2011 Mar 1;104(5):769-80. doi: 10.1038/bjc.2011.21. Epub 2011 Feb 8. Br J Cancer. 2011. PMID: 21304529 Free PMC article.
24 results